Is EMBCV or XYLD a better dividend investment in 2026?

EMBCV currently yields 6.00% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: XYLD offers higher current income.

What is the dividend yield difference between EMBCV and XYLD?

EMBCV has a forward dividend yield of 6.00% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 5.20 percentage points.

Home › Compare › EMBCV vs XYLD

EMBCV vs XYLD: Dividend Comparison 2026

EMBCV yields 6.00% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EMBCV wins by $3.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EMBCV

● Live price

6.00%

Share price

$33.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.7K

Annual income

$879.62

Full EMBCV calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — EMBCV vs XYLD

📍 EMBCV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EMBCV	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EMBCV + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EMBCV pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMBCV

Annual income on $10K today (after 15% tax)

$510.05/yr

After 10yr DRIP, annual income (after tax)

$747.68/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, XYLD beats the other by $2,100.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMBCV + XYLD for your $10,000?

EMBCV: 50%XYLD: 50%

100% XYLD50/50100% EMBCV

Portfolio after 10yr

$27.8K

Annual income

$2,115.32/yr

Blended yield

7.61%

📊

Analyst Conviction Gap

Where Wall Street is split right now

EMBCV

Analyst Ratings

Hold

Consensus: Hold

Price Target

$36.00

+8.0% upside vs current

Range: $36.00 — $36.00

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMBCV buys

XYLD buys

No recent congressional trades found for EMBCV or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEMBCVXYLD

Forward yield	6.00%	11.20% ✓
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$29.7K ✓	$25.9K
Annual income after 10y	$879.62	$3,351.03 ✓
Total dividends collected	$7.4K	$20.2K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: EMBCV vs XYLD ($10,000, DRIP)

Year	EMBCV Portfolio	EMBCV Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$11,300	$600.06	$10,840	$1,120.44	+$460.00 → EMBCV
2	$12,725	$633.71	$11,786	$1,249.59	+$939.00 → EMBCV
3	$14,282	$666.93	$12,854	$1,397.78	+$1.4K → EMBCV
4	$15,982	$699.59	$14,063	$1,568.33	+$1.9K → EMBCV
5	$17,832	$731.62	$15,434	$1,765.19	+$2.4K → EMBCV
6	$19,843	$762.92	$16,995	$1,993.14	+$2.8K → EMBCV
7	$22,026	$793.43	$18,777	$2,257.95	+$3.2K → EMBCV
8	$24,391	$823.07	$20,818	$2,566.58	+$3.6K → EMBCV
9	$26,950	$851.82	$23,163	$2,927.50	+$3.8K → EMBCV
10	$29,716	$879.62	$25,865	$3,351.03	+$3.9K → EMBCV

EMBCV vs XYLD: Complete Analysis 2026

EMBCV — Stock

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Full EMBCV Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this EMBCV vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMBCV vs SCHD EMBCV vs JEPI EMBCV vs O EMBCV vs KO EMBCV vs MAIN EMBCV vs QYLD EMBCV vs JEPQ EMBCV vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.